|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 25/02 | (2006.01) |
| (11) | Number of the document | 3972643 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20729653.4 |
| Date of filing the European patent application | 2020-05-21 | |
| (97) | Date of publication of the European application | 2022-03-30 |
| (45) | Date of publication and mention of the grant of the patent | 2025-05-14 |
| (46) | Date of publication of the claims translation | 2025-07-10 |
| (86) | Number | PCT/EP2020/064234 |
| Date | 2020-05-21 |
| (87) | Number | WO 2020/234432 |
| Date | 2020-11-26 |
| (30) | Number | Date | Country code |
| 201907153 | 2019-05-21 | GB |
| (72) |
BLANCHETOT, Christophe , BE
BUDDING, Kevin , NL
HACK, Erik , NL
SILENCE, Karen , BE
VAN DE WALLE, Inge , BE
VAN DER POL, Ludo , NL
BOROSS, Peter , NL
|
| (73) |
argenx BV ,
Industriepark-Zwijnaarde 7, 9052 Gent,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Komplemento sistemos antagonistai, skirti naudoti paraproteineminių neuropatijų gydymo būduose |
| ANTAGONISTS OF THE COMPLEMENT SYSTEM FOR USE IN METHODS OF TREATING PARAPROTEINEMIC NEUROPATHIES |
| Payment date | Validity (years) | Amount | |
| 2025-06-18 | 6 | 139.00 EUR |
| 2026-05-21 |